Neuregulin signaling through a PI3K/Akt/Bad pathway in Schwann cell survival

Yiwen Li, Gihan I. Tennekoon, Morris Birnbaum, Mark A. Marchionni, J. Lynn Rutkowski

Research output: Contribution to journalArticlepeer-review

100 Scopus citations


β-Neuregulin (βNRG) is a potent Schwann cell survival factor that binds to and activates a heterodimeric ErbB2/ErbB3 receptor complex. We found that NRG receptor signaling rapidly activated phosphoinositide 3-kinase (PI3K) in serum-starved Schwann cells, while PI3K inhibitors markedly exacerbated apoptosis and completely blocked NRG-mediated rescue. NRG also rapidly signaled the phosphorylation of mitogen-activated protein kinase (MAPK) and the serine/threonine kinase Akt. The activation of Akt and MAPK in parallel pathways downstream from PI3K resulted in the phosphorylation of Bad at different serine residues. PI3K inhibitors that blocked NRG-mediated rescue also blocked the phosphorylation of Akt, MAPK, and Bad. However, selective inhibition of MEK-dependent Bad phosphorylation downstream from PI3K had no effect on NRG-mediated survival. Conversely, ectopic expression of wild-type Akt not only enhanced Bad phosphorylation but also enhanced autocrine- and NRG-mediated Schwann cell survival. Taken together, these results demonstrate that NRG receptor signaling through a PI3K/Akt/Bad pathway functions in Schwann cell survival.

Original languageEnglish (US)
Pages (from-to)761-767
Number of pages7
JournalMolecular and Cellular Neuroscience
Issue number4
StatePublished - 2001
Externally publishedYes

ASJC Scopus subject areas

  • Molecular Biology
  • Cellular and Molecular Neuroscience
  • Cell Biology


Dive into the research topics of 'Neuregulin signaling through a PI3K/Akt/Bad pathway in Schwann cell survival'. Together they form a unique fingerprint.

Cite this